Companies: 49,247 Total Market Cap: 132748422762186.78

Fresh2 Group Limited

OTC-FREHY
Biological Products, Except Diagnostic Substances
Rank #48593
Market Cap 222,260
Volume 287
Price 0.10
Change (%) 0.00%
Country or region United States United States

Fresh2 Group Limited's latest marketcap:

222,260

As of 05/21/2025, Fresh2 Group Limited's market capitalization has reached $222,260. According to our data, Fresh2 Group Limited is the 48593th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 222,260
Revenue (ttm) 2.34 M
Net Income (ttm) -17,178,274
Shares Out 2.22 M
EPS (ttm) -38.77
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 05/15/2025
Market Cap Chart
Data Updated: 05/21/2025

Fresh2 Group Limited's yearly market capitalization.

Fresh2 Group Limited has seen its market value drop from $59.37 M to $222,260 since 2020, representing a total decrease of 99.63% and an annual compound decline rate (CAGR) of 72.02%.
Date Market Cap Change (%)
05/21/2025 $222,260 -88.24%
12/23/2024 $1.89 M -85.37%
12/29/2023 $12.91 M 35.27%
12/30/2022 $9.54 M -50.78%
12/31/2021 $19.39 M -67.33%
12/31/2020 $59.37 M

Company Profile

About Fresh2 Group Limited

Fresh2 Group Limited is a biotechnology company specializing in multi-cancer screening and detection solutions. Utilizing advanced cancer differentiation analysis technology, the company provides innovative testing services to corporations and life insurance providers across the People’s Republic of China.

Core Offerings

  • Cancer Screening & Detection: Cutting-edge tests for early cancer identification.
  • Health Services: Comprehensive physical checkup packages.
  • Technology Solutions: Market research, design, coding, development, and testing services.
  • Product Sales: Genetic testing kits and premium skincare products.
  • E-Commerce Platform: Connects food suppliers with supermarkets and restaurants.

Technology & Innovation

The company owns proprietary core technology platforms and is actively engaged in research, development, and distribution of advanced biotech products.

Corporate Background

Formerly known as AnPac Bio-Medical Science Co., Ltd., the company rebranded to Fresh2 Group Limited in April 2023. Founded in 2010, it is headquartered in New York, New York.

Frequently Asked Questions

As of 05/21/2025, Fresh2 Group Limited (including the parent company, if applicable) has an estimated market capitalization of $222,260 USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Fresh2 Group Limited global market capitalization ranking is approximately 48593 as of 05/21/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region United States
Founded 2010
IPO Date n/a
Employees 75
CEO Haohan Xu
Sector
Industry Biological Products, Except Diagnostic Substances
Address 650 5th Ave
New York, 10019-6108
United States
Website https://fresh2.co
People Also Watch
LON-0MTD
412.49 0.00%
ALK-Abelló A/S
228 0.00%
KOSDAQ-950160
25.70 0.00%
FRA-BIO
48.25 0.00%